--- title: Corteva (CTVA) — intrinsic value and fair price canonical: https://sweetvaluelab.com/stocks/ctva ticker: CTVA as_of: 2026-10-17 sector: Basic Materials industry: Agricultural Inputs --- # Corteva (CTVA) Corteva (CTVA) closed at $12.88 on Oct 16, 2026, undervalued by 65% vs its model value of $36.54 (from a five-year discounted cash flow). ## Key figures | Figure | Value | | --- | ---: | | Last close | $12.88 (Oct 16, 2026) | | Model value (from a five-year discounted cash flow) | $36.54 | | Price vs model | undervalued by 65% vs model | | Range of that model | $27.12 – $75.73 | | Market value | $8.6B | | P/E (fiscal 2025) | 8.1 | | Net margin (fiscal 2025) | 6.3% | | Free cash flow (fiscal 2025) | $2.8B | | Dividend yield (trailing twelve months) | 5.59% | | Beta | 0.58 | | Cost of capital (WACC) | 7.35% | | Business classification | Dividend Payer (Low/slowing growth (~1% recent), Moderate margins (6% net margin), Strong dividend yield, Highly cyclical earnings, Strong FCF yield (32.8%)) | ## On the stock lists | List | Place | Figure | Page | | --- | ---: | ---: | --- | | Highest dividend yield | #18 | 5.59% | https://sweetvaluelab.com/lists/highest-dividend-yield | | Highest free cash flow yield | #1 | 32.8% | https://sweetvaluelab.com/lists/highest-free-cash-flow-yield | | Lowest P/E | #10 | 8.1× | https://sweetvaluelab.com/lists/lowest-pe | | Worst performing this year | #1 | −80.8% | https://sweetvaluelab.com/lists/worst-performing-this-year | ## Dividends | Figure | Value | | --- | ---: | | Trailing dividend yield | 5.59% | | Dividends per share, last 12 months | $0.72 | | Dividends / free cash flow (fiscal 2025) | 16.9% | | Raised | 5 years in a row | | Growth over 5 years | 6.3% a year | | Latest payment | $0.18, ex-date Sep 1, 2026, paid Sep 15, 2026 | | Year of payments | Dividends per share | | --- | ---: | | To Aug 12, 2021 | $0.53 | | To Aug 11, 2022 | $0.57 | | To Aug 31, 2023 | $0.61 | | To Sep 3, 2024 | $0.65 | | To Sep 2, 2025 | $0.69 | | Trailing twelve months (to Sep 1, 2026) | $0.72 | ## Valuation models Each model's value per share and the role the engine gave it for this business. The headline above is one model's value; every other model is listed with its own, and each has a page of its own under the valuation. Computed Oct 17, 2026. | Model | Role | Value per share | Low | High | | --- | --- | ---: | ---: | ---: | | DCF · Perpetuity growth · 5y | primary | $36.54 | $27.12 | $75.73 | | DCF · Perpetuity growth · 10y | cross check | $30.25 | $24.30 | $53.69 | | DCF · EBITDA exit · 5y | cross check | $27.09 | $19.78 | $35.75 | | DCF · EBITDA exit · 10y | cross check | $25.84 | $21.05 | $32.27 | | P/E · peers | cross check | $37.56 | $20.91 | $54.22 | | P/E · own history | cross check | $51.60 | $34.08 | $56.92 | | PEG | sanity check | $4.57 | $4.57 | $4.57 | | EV/EBITDA · peers | cross check | $33.83 | $33.83 | $33.83 | | EV/Revenue · peers | cross check | $11.93 | $8.23 | $31.36 | | Earnings power value | cross check | $5.50 | $5.05 | $6.18 | | Dividend discount | cross check | $16.64 | $11.17 | $28.58 | ## Insider activity (SEC Form 4) No open-market insider buys or sales filed in the past 90 days. | Date | Insider | Relationship | Transaction | Shares | Value | | --- | --- | --- | --- | ---: | ---: | | Oct 1, 2026 | TITUS BRIAN | See Remarks | Other | 13,315.132 | $0 | | Oct 1, 2026 | TITUS BRIAN | See Remarks | Other | 14,393 | $0 | | Oct 1, 2026 | TITUS BRIAN | See Remarks | Other | 17,661 | $0 | | Oct 1, 2026 | TITUS BRIAN | See Remarks | Other | 14,772 | $0 | | Oct 1, 2026 | TITUS BRIAN | See Remarks | Other | 11,083 | $0 | ## Recent SEC filings | Filed | Form | What | Filing | | --- | --- | --- | --- | | Oct 13, 2026 | 8-K | 8.01 Other Events | https://www.sec.gov/Archives/edgar/data/1755672/000119312526419637/d405395d8k.htm | | Oct 7, 2026 | 8-K | 5.02 Departure/Election of Directors or Officers | https://www.sec.gov/Archives/edgar/data/1755672/000119312526417064/ck0001755672-20261001.htm | | Oct 7, 2026 | 8-K | 3.03 Modification to Security-Holder Rights; 8.01 Other Events; 9.01 Financial Statements and Exhibits | https://www.sec.gov/Archives/edgar/data/1755672/000119312526417062/ck0001755672-20261001.htm | | Oct 5, 2026 | 8-K | 1.01 Entry into a Material Agreement; 2.01 Completion of Acquisition/Disposition; 9.01 Financial Statements and Exhibits | https://www.sec.gov/Archives/edgar/data/1755672/000119312526414490/ck0001755672-20260929.htm | | Oct 1, 2026 | 8-K | 9.01 Financial Statements and Exhibits | https://www.sec.gov/Archives/edgar/data/1755672/000175567226000028/ctva-20261001.htm | ## Superinvestors holding it (latest 13F) | Manager | Quarter | Shares | Value | | --- | --- | ---: | ---: | | Bill Nygren | 2026-06-30 | 16,333,110 | $1.4B | | Bridgewater | 2026-06-30 | 243,050 | $20.6M | | Robert Olstein | 2026-03-31 | 66,000 | $5.5M | | Dodge & Cox | 2026-06-30 | 20,203 | $1.7M | 4 tracked managers in all. ## About Corteva, Inc. operates in the agriculture business. The company operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. I… --- Source: https://sweetvaluelab.com/stocks/ctva (SweetValueLab, free, no account). Prices and statements from Financial Modeling Prep; filings from SEC EDGAR. Research and educational data, not investment advice; nothing here is a recommendation to buy, sell or hold any security.